Why Lumexa Imaging Holdings, Inc.’s (LMRI) Stock Is Up 5.20%
As of Thursday, August 13, Lumexa Imaging Holdings, Inc.’s LMRI share price has surged by 5.20%, which has investors questioning if this is right time to sell.Jenna Brashear
Stock Evaluator: Lumexa Imaging Holdings, Inc. (LMRI)
Lumexa Imaging Holdings, Inc. LMRI
$11.85
-0.14
-1.17%
August 19, 2026 4:00:00 PM
EST
Volume: 624,039
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Commentary & Analysis
What You Need to Know About Lumexa Imaging Holdings, Inc.'s Q3 Earnings
Lumexa Imaging Holdings, Inc.'s fiscal Q3 earnings report was released on Wednesday, August 12. Let's dive in to see if (LMRI) missed or beat analyst's expectations.Jenna Brashear
Is Lumexa Imaging Holdings, Inc. (LMRI) Overvalued?
We dive into why Lumexa Imaging Holdings, Inc. (LMRI) could be considered overvalued on 2026-08-07, based on AAII’s Value Score and Grade.Tudor Pop
Why Lumexa Imaging Holdings, Inc.’s (LMRI) Stock Is Up 5.19%
As of Monday, August 03, Lumexa Imaging Holdings, Inc.’s LMRI share price has surged by 5.19%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Lumexa Imaging Holdings, Inc.’s (LMRI) Stock Is Up 5.07%
As of Friday, July 24, Lumexa Imaging Holdings, Inc.’s LMRI share price has surged by 5.07%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | LMRI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,121.7 | $1,982.5 | 46% |
|
| Shares Out (Mil) | 96.0 | 77.7 | 61% |
|
| Institutional Ownership | 96.2% | 86.1% | 69% |
|
| Float (Mil) | 22.1 | 52.1 | 31% |
|
| Beta | na | 0.75 | na |
|
| Avg Daily Volume (000s) | 693 | 637 | 63% |
|
| Price Change (52-week) |
na | 79.7% | na |
|
| Growth | LMRI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 10.9% | na |
|
| Net Income (5yr) | na | (1.6%) | na |
|
| EPS (5yr) | na | 0.3% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (17.9%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 6 | 6 | 6 | |
| Current EPS | $0.186 | $0.771 | $0.910 | |
| Month Ago EPS | $0.192 | $0.706 | $0.900 | |
| # Rev Up | 2 | 1 | 2 | |
| # Rev Down | 2 | 3 | 2 | |
| Three Months Ago EPS | $0.210 | $0.694 | $0.960 | |
| Year/Year Chg | 541.4% | (216.1%) | (257.1%) | |
| Financials | LMRI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,043 | $1,504 | 51% |
|
| Net Income (TTM) (Mil) | ($28) | $28 | 21% |
|
| EPS (TTM) | ($0.329) | $0.200 | 31% |
|
| Operating Cash Flow (TTM) (Mil) | $65 | $162 | 48% |
|
| Net Cash Flow (TTM) (Mil) | $67 | $9 | 73% |
|
| Long-Term Debt (Q1) (Mil) | $933 | $338 | 65% |
|
| Enterprise Value (Q1) (Mil) | na | $2,416 | na |
|
| Valuation | LMRI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.82 | 2.79 | 47% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | LMRI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 14.8% | 27.8% | 14% |
|
| Net Margin | (2.7%) | 1.2% | 28% |
|
| ROA | (3.1%) | 2.2% | 32% |
|
| ROE | (7.1%) | 7.2% | 29% |
|
| Liabilities to Assets | 66.0% | 58.6% | 61% |
|
| F-Score | 2 | 5 | na |
|
Lumexa Imaging Holdings, Inc. did not pass any screens on 8/20/2026.
